CN Stock MarketDetailed Quotes

Shanghai Kehua Bio-engineering (002022)

Watchlist
  • 5.97
  • +0.04+0.67%
Market Closed Apr 30 15:00 CST
3.07BMarket Cap-4.22P/E (TTM)

Shanghai Kehua Bio-engineering (002022) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Self-made product802.81M48.88%
Agent product771.02M46.94%
Other68.65M4.18%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnosis industry1.64B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic1.18B71.79%
Abroad463.4M28.21%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More